Safety Comparison of 40- vs 60-mg/day Doses of Oral Octreotide Capsules for Treatment of Acromegaly in the CHIASMA OPTIMAL Trial

Authors
Category Primary study
JournalJournal of the Endocrine Society
Year 2022
This article has no abstract
Epistemonikos ID: a296059bea8d487e27187e769815258ad11375dc
First added on: Dec 07, 2023